MAY 20, 2021 8:00 AM PDT

Gonorrhea Testing on the Go

WRITTEN BY: Tara Fernandez

Forget lab-based tests—a new portable microfluidic device links to a mobile app, diagnosing gonorrhea in just 15 minutes. The PROMPT (portable, rapid, on-cartridge, magnetofluidic purification and testing platform) device can also tell if frontline antibiotics will be effective against the particular strain detected.

“Our portable, inexpensive testing platform has the potential to change the game when it comes to diagnosing and enabling rapid treatment of sexually transmitted infections,” said study lead Tza-Huei Wang.

“It ensures that patients are diagnosed on the spot, and treatment can begin immediately, improving clinical outcomes. This will be especially valuable in low-resource settings, where well-equipped laboratories are not always available to every patient.”

Gonorrhea is a sexually transmitted disease resulting from infection with the Neisseria gonorrhoeae bacterium. Over 87 million people around the world are affected by the infection. Besides these staggering statistics, the emergence of several antibiotic-resistant strains of the bacteria is also concerning for public health experts.  

New cost-effective technologies like PROMPT that can diagnose the condition using a simple procedure could be transformative, particularly in low-resource areas. Here, a swab of the patient sample is mixed with magnetized particles in a tube before being loaded into a cartridge. The device, which runs on a five-volt battery, runs through 40 cycles of the polymerase chain reaction before the data indicating a positive or negative test are transmitted to a connected mobile phone.

The PROMPT device was tested in the field, deployed to sexual health clinics in Baltimore and Kampala in Uganda. It was found to accurately detect the most common gonorrhea bacterial strain with an accuracy rate of 97 percent. PROMPT was 100% accurate in detecting whether or not the gonorrhea strain would respond to the antibiotic ciprofloxacin.

“We expect to be able to deliver these products to those who can really benefit from them in two to three years,” said Want, whose team is creating a spin-off company to commercialize their innovation.

 


Source: Science Translational Medicine, Johns Hopkins University.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
OCT 14, 2021
Clinical & Molecular DX
Cancer-Sniffing Worms: The Future of Diagnostics?
OCT 14, 2021
Cancer-Sniffing Worms: The Future of Diagnostics?
Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, i ...
NOV 02, 2021
Coronavirus
COVID vaccines have saved 245,000 lives and counting
NOV 02, 2021
COVID vaccines have saved 245,000 lives and counting
What began in December 31, 2019 as a cluster of cases of pneumonia with an unknown etiology, quickly spread throughout t ...
NOV 16, 2021
Clinical & Molecular DX
Still a Way to Go Before AI Can Help Patients on Ventilators
NOV 16, 2021
Still a Way to Go Before AI Can Help Patients on Ventilators
Computers aren’t ever going to replace doctors completely. Instead, artificial intelligence (AI) has the potential ...
NOV 16, 2021
Clinical & Molecular DX
Algorithm Mines Big Data, Finds Gene Linked to Psychiatric Disease
NOV 16, 2021
Algorithm Mines Big Data, Finds Gene Linked to Psychiatric Disease
We have a wealth of human genome data overlaid with gene ‘hotspots’ linked to the development of particular ...
NOV 25, 2021
Clinical & Molecular DX
Cactus Spines Inspire Diagnostic Tools Without the Prick
NOV 25, 2021
Cactus Spines Inspire Diagnostic Tools Without the Prick
Did you know that there are over 1700 species of cacti—spiny plants that have evolved to survive some of the harsh ...
Loading Comments...